ADAI News & Events
December 20, 2024
WATCH: What’s the Latest: Assessment & Treatment of Alcohol Use Disorder (Dec. 2024 webinar)
Alcohol use disorder (AUD) affects millions of individuals and remains one of the leading causes of preventable death worldwide. Despite its prevalence, AUD is often underdiagnosed and undertreated. This webinar from the UW ADAI State Opioid Response Team (SOR) will explore the importance of assessing and treating AUD and provide an overview of the evidence…
December 18, 2024
New ADAI Articles: Pharmacy Staff and Naloxone & PReP Use by MSM Who Use Substances
Two new papers by ADAI researchers and colleagues are now available! Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains. Green TC, Silcox J, Bolivar D, Gray M, Floyd AS, et al. J Amer Pharm Assoc 2024;64(1):71-78. [subscription access] This paper…
December 16, 2024
Northwest ATTC webinar: Eliminating Hepatitis C (Jan 22, 12pm PT)
Join the Northwest Addiction Technology Transfer Center (ATTC) at the UW Addictions, Drug & Alcohol Institute on January 22, 2025 (12-1pm PT) to learn about Hepatitis C from the Executive Director of the Hepatitis Education Project (HEP), Apoorva Mallya! Mallya will be talking about the prevalence of Hepatitis C virus (HCV) in the U.S., a…
December 9, 2024
ADAI Lunch & Learn: Pipe Distribution Through a Syringe Services Program to Reduce Higher Risk Drug Consumption (Jan 16, 12pm PT)
Join ADAI and presenter Tom Fitzpatrick, MD (UW Physician & Infectious Diseases Fellow) for our next ADAI Lunch & Learn! In this session, Dr. Fitzpatrick will present interim results from his ADAI Small Grants Project. Heroin, fentanyl, methamphetamine, and cocaine can be injected or smoked. Distributing pipes may encourage people who use drugs (PWUD) to…
December 3, 2024
What’s New in Harm Reduction Research (December 2024)
A review of recently published research on harm reduction topics – December 2024. Need help getting copies of any of these articles? Email Meg Brunner, MLIS (meganw@uw.edu). Free articles have “(open access)” after the titles; all other articles require a subscription to access. Facilitators and barriers to monitoring and evaluation at syringe service programs. (open access)…
November 14, 2024
New from CERP Director Beatriz Carlini: Report & Recommendations of the High Potency Cannabis Think Tank to the State of California
ADAI’s Cannabis Education & Research Program Director Beatriz Carlini, PhD, MPH is one of the co-authors of a new report: “Report and Recommendations of the High Potency Cannabis Think Tank to the State of California.” This report was prepared by a committee of scientists (including Dr. Carlini) and medical experts convened by the California Department…
October 25, 2024
ADAI’s CAAHS is Hiring! NWATTC Project Coordinator & ORN Indigenous Communities Tech Transfer Specialist
ADAI’s Center for Advancing Addiction Health Services (CAAHS) is recruiting for two new positions. Click the links below to find out more about each one and apply! Opioid Response Network Indigenous Communities Technology Transfer Specialist (Req 240043): This position will facilitate access to training, consultation, and guidance resources on evidence-based opioid and stimulant use disorder…
October 16, 2024
ADAI Lunch & Learn Webinar: A Socio-Ecological Approach to Deriving Insights about Stigma Relating to Substance Use (Nov. 14, 12pm PT)
Presenter:Annie Chen, PhDAssociate ProfessorUW Department of Biomedical Informatics and Health Education Stigma relating to substance use disorder can have negative impacts in many aspects of those affected, including but not limited to physical and mental health, employment, housing, social relationships, and reluctance to seek treatment. Despite these consequences, questions remain concerning how stigma occurs, the…
October 14, 2024
2024 ADAI Symposium: Slides & Recordings Available
ADAI hosted a day-long research symposium on September 19, 2024 about “Cannabis, Schizophrenia, and Other Psychotic Disorders,” featuring experts like Marta Di Forti, MD, PhD of King’s College (UK) and Deepak Cyril D’Souza, MD of Yale University. Presentations covered the past, present, and future of cannabis use and psychosis; reviewing the evidence; promising clinical interventions…
September 20, 2024
New ADAI Research: Community-Based Medications First for Opioid Use Disorder
Citation: Banta-Green CJ, Owens MD, Williams JR, Floyd AS, Williams-Gilbert W, Kingston S. Community-based medications first for opioid use disorder – Care utilization and mortality outcomes. Substance Abuse and Rehabilitation 2024;15:173-183. The most effective and evidence-based treatments for opioid use disorder (OUD) are medications for OUD (MOUD) like buprenorphine, methadone, and extended-release injectable naltrexone. However,…
Next page
